SSA/Ro52 autoantigen interacts with Dcp2 to enhance its decapping activity

Biochemical and Biophysical Research Communications

Volumn 370, Issue 1, 2008, Pages 195-199

  Yamochi, Tadanori ^a   Ohnuma, Kei ^a   Hosono, Osamu ^a   Tanaka, Hirotoshi ^a   Kanai, Yoshiyuki ^a   Morimoto, Chikao ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autoantibody; Autoantigen; Decapping enzyme; hDCP2; mRNA decay; p bodies; Ro52

Indexed keywords

AUTOANTIGEN; BINDING PROTEIN; DCP2 PROTEIN; RO52 ANTIGEN; SSA ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL STIMULATION; CONGENITAL HEART BLOCK; DOSE RESPONSE; IMMUNOPRECIPITATION; PLASMID; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RNA METABOLISM; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIGENS; CATALYSIS; CYTOPLASM; ENDORIBONUCLEASES; HUMANS; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; RIBONUCLEOPROTEINS; RNA CAPS; RNA STABILITY;

EID: 41849103370     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.075     Document Type: Article

References (32)

1. Alspaugh M.A., and Tan E.M. Antibodies to cellular antigens in Sjogren's syndrome. J. Clin. Invest. 55 (1975) 1067-1073
2. Rader M.D., O'Brien C., Liu Y.S., Harley J.B., and Reichlin M. Heterogeneity of the Ro/SSA antigen. Different molecular forms in lymphocytes and red blood cells. J. Clin. Invest. 83 (1989) 1293-1298
3. Deutscher S.L., Harley J.B., and Keene J.D. Molecular analysis of the 60-kDa human Ro ribonucleoprotein. Proc. Natl. Acad. Sci. USA 85 (1988) 9479-9483
4. Chan E.K., Di Donato F., Hamel J.C., Tseng C.E., and Buyon J.P. 52-kD SS-A/Ro: genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart. J. Exp. Med. 182 (1995) 983-992
5. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., and Ballabio A. The tripartite motif family identifies cell compartments. EMBO J. 20 (2001) 2140-2151
6. Chan E.K., Hamel J.C., Buyon J.P., and Tan E.M. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J. Clin. Invest. 87 (1991) 68-76
7. Ben-Chetrit E., Chan E.K., Sullivan K.F., and Tan E.M. A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J. Exp. Med. 167 (1988) 1560-1571
8. Harley J.B., Alexander E.L., Bias W.B., Fox O.F., Provost T.T., Reichlin M., Yamagata H., and Arnett F.C. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjogren's syndrome. Arthritis Rheum. 29 (1986) 196-206
9. Dorner T., Feist E., Held C., Conrad K., Burmester G.R., and Hiepe F. Differential recognition of the 52-kd Ro(SS-A) antigen by sera from patients with primary biliary cirrhosis and primary Sjogren's syndrome. Hepatology 24 (1996) 1404-1407
10. Ishii T., Ohnuma K., Murakami A., Takasawa N., Yamochi T., Iwata S., Uchiyama M., Dang N.H., Tanaka H., and Morimoto C. SS-A/Ro52 an autoantigen involved in CD28-mediated IL-2 production. J. Immunol. 170 (2003) 3653-3661
11. Yu J.H., Yang W.H., Gulick T., Bloch K.D., and Bloch D.B. Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body. RNA 11 (2005) 1795-1802
12. Eystathioy T., Peebles C.L., Hamel J.C., Vaughn J.H., and Chan E.K. Autoantibody to hLSm4 and the heptameric LSm complex in anti-Sm sera. Arthritis Rheum. 46 (2002) 726-734
13. Eystathioy T., Chan E.K., Takeuchi K., Mahler M., Luft L.M., Zochodne D.W., and Fritzler M.J. Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182. J. Mol. Med. 81 (2003) 811-818
14. Bhanji R.A., Eystathioy T., Chan E.K., Bloch D.B., and Fritzler M.J. Clinical and serological features of patients with autoantibodies to GW/P bodies. Clin. Immunol. 125 (2007) 247-256
15. van Dijk E., Cougot N., Meyer S., Babajko S., Wahle E., and Seraphin B. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 21 (2002) 6915-6924
16. Fenger-Gron M., Fillman C., Norrild B., and Lykke-Andersen J. Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol. Cell 20 (2005) 905-915
17. Cougot N., Babajko S., and Seraphin B. Cytoplasmic foci are sites of mRNA decay in human cells. J. Cell Biol. 165 (2004) 31-40
18. Sheth U., and Parker R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300 (2003) 805-808
19. Eystathioy T., Jakymiw A., Chan E.K., Seraphin B., Cougot N., and Fritzler M.J. The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies. RNA 9 (2003) 1171-1173
20. Ingelfinger D., Arndt-Jovin D.J., Luhrmann R., and Achsel T. The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci. RNA 8 (2002) 1489-1501
21. Fillman C., and Lykke-Andersen J. RNA decapping inside and outside of processing bodies. Curr. Opin. Cell Biol. 17 (2005) 326-331
22. Dunckley T., and Parker R. The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J. 18 (1999) 5411-5422
23. Lykke-Andersen J. Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol. Cell Biol. 22 (2002) 8114-8121
24. Ohnuma K., Yamochi T., Uchiyama M., Nishibashi K., Yoshikawa N., Shimizu N., Iwata S., Tanaka H., Dang N.H., and Morimoto C. CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1. Proc. Natl. Acad. Sci. USA 101 (2004) 14186-14191
25. Yamochi T., Nishimoto I., Okuda T., and Matsuoka M. ik3-1/Cables is associated with Trap and Pctaire2. Biochem. Biophys. Res. Commun. 286 (2001) 1045-1050
26. Pourmand N., Blange I., Ringertz N., and Pettersson I. Intracellular localisation of the Ro 52 kD auto-antigen in HeLa cells visualised with green fluorescent protein chimeras. Autoimmunity 28 (1998) 225-233
27. Eystathioy T., Chan E.K., Tenenbaum S.A., Keene J.D., Griffith K., and Fritzler M.J. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol. Biol. Cell 13 (2002) 1338-1351
28. Teixeira D., Sheth U., Valencia-Sanchez M.A., Brengues M., and Parker R. Processing bodies require RNA for assembly and contain nontranslating mRNAs. RNA 11 (2005) 371-382
29. Zhang S., Williams C.J., Wormington M., Stevens A., and Peltz S.W. Monitoring mRNA decapping activity. Methods 17 (1999) 46-51
30. Yang Y., Eversole T., Lee D.J., Sontheimer R.D., and Capra J.D. Protein-protein interactions between native Ro52 and immunoglobulin G heavy chain. Scand. J. Immunol. 49 (1999) 620-628
31. Piccirillo C., Khanna R., and Kiledjian M. Functional characterization of the mammalian mRNA decapping enzyme hDcp2. RNA 9 (2003) 1138-1147
32. Frank M.B. Characterization of DNA binding properties and sequence specificity of the human 52 kDa Ro/SS-A (Ro52) zinc finger protein. Biochem. Biophys. Res. Commun. 259 (1999) 665-670